Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01185 (
vasopressin
)
23,126
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effects of vasoconstrictors on membrane potential of endothelium of intact rat aorta were investigated using the patch-clamp technique.
Norepinephrine
, endothelin (ET)-1, 5-hydroxytryptamine (5-HT),
vasopressin
, and angiotensin II evoked depolarization and oscillations in membrane potential. The alpha 1-adrenoreceptor agonist phenylephrine (PE), but not the alpha 2-agonist clonidine or the beta-agonist isoproterenol, evoked oscillations. The antagonist of 5-HT2-receptors, ketanserin, inhibited 5-HT-evoked oscillations. ET-3, unlike ET-1, did not evoke oscillations. The antagonists of voltage-operated Ca2+ channels, nifedipine and verapamil, inhibited vasoconstrictor-evoked oscillations, and the Ca2+ channel agonist BAY K 8644 enhanced oscillations. Acetylcholine and sodium nitroprusside inhibited PE-evoked oscillations. The inhibitors of NO synthase, N omega-nitro-L-arginine and NG-methyl-L-arginine, as well as methylene blue, enhanced oscillations. The intima of rat aorta with endothelium was removed from underlying smooth muscle. In this preparation, acetylcholine evoked a response similar to that in the intact vessel, but PE and ET-1 were without effect. These data suggest that vasoconstrictors acting on receptors on aortic smooth muscle evoke a response that is transferred to the endothelium and evokes depolarization and oscillations in endothelial membrane potential.
...
PMID:Smooth muscle cells affect endothelial membrane potential in rat aorta. 806 36
1. We have studied the influence of mechanical loading conditions on the responses of cannulated rat mesenteric small arteries to noradrenaline,
vasopressin
and potassium. 2. The cross-sectional area (CSA) of vessels was continuously monitored. Isometric loading (CSA-controlled conditions) or isobaric loading (pressure-controlled conditions) was achieved by feedback adjustment of the distending pressure. 3.
Noradrenaline
(0.3 microM) and
vasopressin
(0.05 u l-1) induced myogenic responsiveness, resulting in a constant or declining CSA with increasing pressure. Potassium (32 mM) induced weak myogenic responsiveness. 4. At a constant pressure of 60 cmH2O, noradrenaline and
vasopressin
concentration-response curves were graded, the concentration-response curves of individual vessels being extended over two to three decades. Sensitivity to the vasoconstrictors, expressed as pD2 values (-log10 EC50), averaged 6.45 +/- 0.18 log M and 1.27 +/- 0.20 log u l-1 for the noradrenaline and
vasopressin
concentration-response curves respectively. The isobaric pD2 for K+ was 1.54 +/- 0.07 log M. 5. During CSA-controlled conditions, noradrenaline and
vasopressin
induced all-or-none responses to stretch. Potassium induced graded responses to stretch. 6. During CSA-controlled conditions, noradrenaline and
vasopressin
concentration-response curves also showed all-or-none behaviour. Almost the full response occurred through only a doubling of the concentration. pD2 values were 6.88 +/- 0.38 log M (noradrenaline) and 1.87 +/- 0.43 log u l-1 (
vasopressin
). Isometric vessels were significantly more sensitive to noradrenaline and
vasopressin
than isobaric vessels. Isometric K+ curves were gradual. pD2 was 1.54 +/- 0.07 log M, a value not different from the isobaric value. 7. These findings can be explained by assuming that agonist sensitivity is wall tension dependent, such that sensitivity increases with increasing wall tension. This concept accounts for partial regulation of wall tension during pressure-controlled conditions, as well as instability due to a positive feedback loop of active tension development and tension-induced sensitization during CSA-controlled conditions.
...
PMID:Role of wall tension in the vasoconstrictor response of cannulated rat mesenteric small arteries. 807 77
1. The renal effects of incremental doses of intravenously infused noradrenaline were evaluated in normal subjects during two different water loads, 5 ml/kg (n = 6) and 20 ml/kg (n = 9), producing conditions of euhydration and overhydration, respectively. 2.
Noradrenaline
infusion rates ranged from 0.015 to 0.075 microgram min-1 kg-1. In the euhydrated subjects, noradrenaline caused a dose-dependent fall in urinary sodium excretion and an increase in urinary flow rate. During overhydration similar doses of noradrenaline caused a fall in urinary sodium excretion but a decrease in urinary flow rate. 3. Although there was no detectable change in glomerular filtration rate, a dose-dependent fall in effective renal plasma flow was observed in both hydration states during noradrenaline infusion. 4.
Noradrenaline
infusion was associated with a dose-dependent increase in proximal tubular sodium reabsorption as assessed by the lithium clearance method. Fractional reabsorption of sodium by the distal nephron was, however, unchanged by noradrenaline in both hydration states. 5. Plasma
vasopressin
concentration was unchanged by noradrenaline in euhydrated subjects. The renin-angiotensin-aldosterone axis was stimulated by noradrenaline in both euhydrated and overhydrated subjects. 6. Thus we conclude that plasma circulating noradrenaline has a dose-dependent antinatriuretic effect in man. The antinatriuretic effect of noradrenaline is mediated mainly at the proximal tubule in man. We have also shown that during overhydration, noradrenaline decreased urinary flow rate. In contrast, in euhydrated subjects, noradrenaline increased urinary flow rate with no accompanying changes in plasma
vasopressin
concentration, which suggests a direct effect of noradrenaline on the renal tubular permeability to water.
...
PMID:Effect of noradrenaline on renal sodium and water handling in euhydrated and overhydrated man. 822 16
1. Neurotransmitters released from nerve endings are inactivated by re-uptake into the presynaptic nerve terminals and possibly into neighbouring glial cells. While analysing the functional properties of alpha 1-adrenoceptors in the hypothalamus, we observed a high-affinity uptake process for noradrenaline in postsynaptic peptidergic neurones. 2. In primary hypothalamic cell cultures and in a hypothalamic neuronal cell line, [3H]-prazosin bound with high affinity and was displaced by unlabelled prazosin in concentrations of 10(-10) to 10(-7) M. However, at concentrations of unlabelled prazosin above 10(-7) M, there was a paradoxical increase in apparent [3H]-prazosin binding. 3. Methoxamine, an alpha 1-adrenoceptor ligand that is not subject to significant neuronal uptake, displaced [3H]-prazosin but did not cause the paradoxical increase in the apparent binding of [3H]-prazosin. Cooling the cells to 4 degrees C reduced the total amount of prazosin associated with the cells; under these conditions, methoxamine almost completely inhibited [3H]-prazosin binding to the cells. 4. In the presence of desipramine (DMI), unlabelled prazosin displaced [3H]-prazosin as before, but no paradoxical increase in apparent binding was seen above 10(-7) M. 5. The paradoxical increase of [3H]-prazosin binding was not observed in membrane preparations of hypothalamic neurones. These findings indicated that the paradoxical increase in apparent [3H]-prazosin binding was due to a cellular uptake process that becomes evident at high concentrations of the ligand. 6. DMI (10(-5) M) had no effect on the specific binding of [3H]-prazosin. The presence of alpha1-adrenoceptors was confirmed by binding of [125]-HEAT, but [3H]-idazoxan (an alpha2- ligand) did not bind to the cells.7. The uptake of prazosin obeyed the Michaelis-Menten model, with similar Km and Vmax values in both types of cultures.8.
Noradrenaline
was taken up with high affinity by both types of cultures. (+/-)-[3H]-noradrenaline uptake was reduced by DMI and by excluding sodium from the medium, indicating that this process has some of the properties of uptake 1. (+/-)-[3H]-noradrenaline uptake in the cell line was unaffected by testosterone.9. The measured uptake of (-)-noradrenaline in the cell line was considerably increased by blockade of catechol-omicron-methyl-transferase and monoamine oxidase, suggesting that (-)-noradrenaline is metabolized to lipophilic products that escape across the plasma membrane.10. Studies in rats, in which the noradrenaline isomer 6-hydroxydopamine was used, suggested that the post synaptic uptake process is operative in hypothalamic CRH and
vasopressin
neurones in vivo.11. The Km for (-)-noradrenaline was within the range for the high affinity uptake, process in noradrenergic neurones. Uptake takes place in concentrations at which noradrenaline activates alpha1-adrenoceptors.Removal of noradrenaline from the vicinity of the receptors may prevent desensitization,thus maintaining the responsiveness of postsynaptic neurones to the actions of the neurotransmitter.
...
PMID:High-affinity uptake of noradrenaline in postsynaptic neurones. 835 34
The effect of dopamine on the arterioles (50.8-95.2 microns) in the cremaster muscle was examined to determine its effect on microcirculation. Anesthetized rats were used under a light microscope connected to a videocamera. Drugs were applied using small round filter paper (370 microns in diameter) containing the drug and placed in the immediate vicinity of the arteriole on the cremaster with a micromanipulator. The dose of the drug applied was represented by concentration of the drug solution in which the filter paper was immersed. Dopamine (10(-6)-10(-4)M) induced neither constriction nor dilation of the arteriole in the cremaster. Papaverine (10(-2)M) did not dilate the arteriole. However, the arterioles were constricted by noradrenaline (10(-6)-10(-4)M) and
vasopressin
(10(-7)M) in a dose-dependent manner.
Noradrenaline
(10(-4)M)-induced constriction was blocked by concomitant application of dopamine (10(-4)M). This effect of dopamine was antagonized by SCH23390 (10(-3)M). However, isoproterenol (10(-3)M) did not affect the arteriole, nor inhibit noradrenaline (10(-4)M)-induced constriction of the arterioles. While forskolin (10(-2)M) alone did not produce constriction or dilation of the arterioles, it inhibited noradrenaline (10(-4)M)-induced constriction of the arteriole. These results suggest that dopamine prevents the constriction of the arteriole induced by noradrenaline, by activation of DA1 receptors, which activates adenylate cyclase.
...
PMID:Inhibitory effects of dopamine on noradrenaline-induced constriction of arterioles in vivo in the striated cremaster muscle. 848 19
Neurohormonal factors may account for the fact that patients with similar severity and duration of hypertension develop different degrees of left ventricular hypertrophy (LVH). The purpose of this work was to compare the pressor hormone profiles of hypertensive subjects off medication during exercise testing. Nineteen patients, stratified according to echocardiographically diagnosed absence (Group I n = 6) or presence (Group II n = 13) of LVH, underwent testing on the treadmill according to the Bruce protocol. Both groups were comparable in age, severity and duration of hypertension and reached similar double product at peak exercise. Measurements of plasma renin activity (PRA), plasma catecholamines and
vasopressin
(AVP) at baseline, peak exercise and post exercise revealed significant differences between groups: Group I had suppressed PRA levels throughout and had significantly higher baseline AVP levels, which increased further at peak effort. Group II had significantly higher baseline PRA levels, which tended to increase further at peak effort, and had suppressed AVP levels throughout. There was a significant negative correlation between percent increments in AVP and increments in double product.
Norepinephrine
increased significantly with effort in both groups, but the levels attained were higher in Group I. In view of the known negative inotropic action of AVP and the trophic effect of angiotensin, we speculate that lower baseline AVP and higher PRA, together with inability of AVP to increase with effort, may be causally related to development of LVH.
...
PMID:Pressor hormone profile during stress in hypertension: does vasopressin interfere with left ventricular hypertrophy? 849 May 95
Neuropeptide Y (NPY) and norepinephrine are co-localized in the noradrenergic projection from the A1 nucleus of the medulla to the vasopressinergic magnocellular neurons of the supraoptic and paraventricular nuclei. Because this pathway is involved in the control of
vasopressin
release, we have examined the possibility that NPY and norepinephrine interact in this control. Because the stimulation of
vasopressin
release by the intracerebroventricular (i.c.v.) administration of norepinephrine is greater in male than in female rats, the experiments were carried out in conscious male rats and in female rats in the proestrous and non-proestrous phases of the estrous cycle. NPY (940 pmol i.c.v.) caused small sustained increases in plasma
vasopressin
concentrations that were greater in proestrous than in non-proestrous females and males.
Norepinephrine
i.c.v. increased plasma
vasopressin
levels transiently and to a greater extent in females than males. When NPY and norepinephrine were given together, the pattern of the
vasopressin
response was similar to that of norepinephrine alone. The magnitude of this response in males and proestrous females did not differ from that to norepinephrine alone; in non-proestrous females the response was twice that to norepinephrine alone. In non-proestrous rats, NPY also enhanced the pressor response to norepinephrine. Thus, NPY interacts centrally with norepinephrine in
vasopressin
release and cardiovascular function and this effect is dependent upon gender and phase of the estrous cycle.
...
PMID:Effects of gender on the central actions of neuropeptide Y and norepinephrine on vasopressin and blood pressure in the rat. 852 7
Independently of phenomena related to rejection, atherosclerosis of the grafted heart or high blood pressure, there exists a qualitative and quantitative degradation of response to exercise in heart transplant recipients. Maximal oxygen consumption is generally reduced to 40 to 60% of normal levels. There are several interactive mechanisms. Paradoxically, the transplanted heart is a clear demonstration of the fact that several other elements are involved in the organisms response to exercise. Indeed, ventilation, exercise load, peripheral circulation, muscle metabolism and neurohormonal response also play a role. Vasoactivity of the peripheral arteries limits distribution and extraction of oxygen during exercise.
Noradrenaline
, renin, atrial natriuretic factor,
vasopressin
and endothelin levels are normal at rest, but an overreaction occurs during exercise. The percentage of type I (oxidative) fibres is reduced in muscles. Cyclosporine has also been shown to have a toxic effect on mitochondria in muscles. The deinnervated transplanted heart is thus called upon to work in coordination with peripheral elements which have also undergone alterations. Consequently, response to exercise cannot be significantly increased above the level reached before transplantation. Usually patients are not greatly hindered in their daily activities and rarely complain of breathlessness. Nevertheless, an improvement would be appreciated. A coherent physical rehabilitation programme can increase maximal oxygen consumption by 25 to 30% in these patients, essentially via improvement in peripheral anomalies. It is more difficult to modify cardiac response.
...
PMID:[Exercise capacity after heart transplantation]. 854 31
Oxytocin (OT) release within the brain is thought to play a major role in inducing maternal behaviour in a number of mammalian species but little is known about the sites of release which are important in this respect. We have investigated whether the paraventricular nucleus of the hypothalamus (PVN) is a site of OT action on maternal behaviour in the sheep. In vivo microdialysis and retrodialysis was used to determine whether OT is released in the region of the PVN during the post-partum induction of maternal behaviour and if its release at this site can stimulate maternal behaviour in non-pregnant animals. In vivo sampling showed that OT concentrations increased significantly in the region of PVN at birth. When OT was retrodialysed bilaterally into the PVN (1 or 10 microM) of multiparous ewes treated with progesterone and oestradiol to stimulate lactation, maternal behaviour was induced in a significant number of animals (1 microM, 6/8 and 10 microM, 5/8) compared with controls (0/8 ewes). Similar infusions of the ring structure of OT, tocinoic acid (TOC-10 microM), also induced maternal behaviour in a significant proportion of animals (5/6 ewes) as did intracerebroventricular (ICV) OT (6/8 ewes) and artificial stimulation of the vagina and cervix (VCS, 8/9 ewes). On the other hand,
vasopressin
(AVP) 1 microM did not induce maternal behaviour in any ewes and a 10 microM dose only induced it in 2/8 animals. The neurochemical changes accompanying the above treatments were also investigated.
Noradrenaline
concentrations increased in the PVN after the retrodialysis administration of OT 1 microM and 10 microM, TOC 10 microM and AVP 1 microM, OT ICV and VCS. Dopamine concentrations were also increased by OT 10 microM, TOC 10 microM, AVP 1microM and OT ICV. Aspartate and glutamate concentrations were significantly reduced by retrodialysis infusions of OT 1 microM and AVP 1 and 10 microM but not by any other treatment. Finally, the retrodialysis infusion of OT and TOC, as well as ICV OT, significantly increased plasma OT release whereas AVP infusions did not. These results provide evidence that OT is released in the PVN during parturition and is important for the induction of maternal behaviour. It seems probable that OT release at this site has a positive feedback effect on both parvocellular and magnocellular OT neurons to facilitate co-ordinated OT release both in central OT terminal regions (to facilitate maternal behaviour) and peripherally into the blood (to facilitate uterine contractions/milk let down). The potential functional roles for the actions of OT on monoamine and amino acid transmitter release in the PVN are discussed.
...
PMID:The role of oxytocin release in the paraventricular nucleus in the control of maternal behaviour in the sheep. 873 Jun 50
The effect of removal of the pituitary on mesenteric arterial function was examined in adult male rats that had undergone hypophysectomy 7 days earlier. Sham-operated rats and weight-matched rats served as controls. The body weight of hypophysectomized rats decreased from 220.75 +/- 0.48 g to 188.03 +/- 2.53 g (n = 7). Sham-operated controls gained weight, from 223 +/- 1.47 to 275.85 +/- 3.45 g (n = 8). Frequency-dependent vasoconstriction to electrical field stimulation (2-32 Hz, 90 V, 1 ms, 30 s) was significantly augmented after hypophysectomy. The maximal constrictor response of hypophysectomized preparations, 215.5 +/- 14.9 mm Hg (n = 6), was approximately twice that of the sham-operated controls, 100 +/- 6.1 mm Hg (n = 7) and weight-matched controls 109.8 +/- 5.8 mm Hg (n = 8).
Norepinephrine
(NE) (0.05-1,500 nmol) elicited dose-dependent vasoconstriction; the maximal response was significantly augmented after hypophysectomy, 221.71 +/- 15.9 (n = 7) as compared with 148.0 +/- 16.0 mm Hg (n = 8) in sham-operated controls and 146.3 +/- 8.7 mm Hg (n = 7) in weight-matched controls. Dose-dependent vasoconstrictor responses to ATP, 5-hydroxytryptamine,
vasopressin
, and endothelin were similar between the groups. High-performance liquid chromatography analysis showed no difference in NE content of the superior mesenteric artery from hypophysectomized and sham-operated controls. Hypophysectomy of rats caused an increase in sympathetic constrictor function of the mesenteric arterial vasculature that appeared to involve postjunctional adrenoceptors rather than prejunctional mechanisms and was not due to arrested growth or the smaller size of the mesenteric preparations.
...
PMID:Vasoconstrictor function of the rat isolated perfused mesenteric arterial bed seven days after hypophysectomy. 890 97
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>